Orano Med
0 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, kn... Read more
Org chart
Julien Dodet
President & CEO of Orano Med
Julien Dodet
Collapse
J. Robert Chastain (Rob)
Senior Manager Quality Assurance Quality Control
Pascal Mirocha
Chief Financial Officer Directeur Administratif ET Financier
Gwenaelle Nourry
Orano Med HR Director
Nicolas Bozovic
Director Of Pharmaceutical Operations And Projects
Julien Torgue
Chief Scientific Officer
Allison Manuel
Senior Clinical Trial Manager
Carter Rose
Senior Production Manager Associate RSO
Haley Lozano-Sprague
QA Manager
Michael Courtney
Logistics Manager
Sadaf Qureshi
QC Manager
Virgil Dodson
Facilities Manager
